Giant Cell Myocarditis after First Dose of BNT162b2 - a Case Report.

Autor:	Hirsch, Valentin G., Schallhorn, Sven, Zwadlo, Carolin, Diekmann, Johanna, Länger, Florian, Jonigk, Danny David, Kempf, Tibor, Schultheiss, Heinz‐Peter, Bauersachs, Johann, Hirsch, V G, Schallhorn, S, Zwadlo, C, Diekmann, J, Länger, F, Jonigk, D D, Kempf, T, Schultheiss, H P, Bauersachs, J
Zdroj:	European Journal of Heart Failure; Jul2022, Vol. 24 Issue 7, p1319-1322, 4p, 1 Color Photograph
Abstrakt:	Herein we report the case of a young man, admitted to the Department of Cardiology and Angiology at Hannover medical school with shortness of breath and elevated Troponin. Few weeks earlier the patient received the first dose of BioNTech´s mRNA-vaccine (Comirnaty, BNT162b2). After diagnostic work-up revealed giant cell myocarditis, the patient received immunosuppressive therapy. In the present context of myocarditis after mRNA-vaccination we discuss this rare aetiology and the patient's treatment strategy in the light of current recommendations. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.